MRCIF(MRCIF)
MRCIF
No analyst ratings available
No analyst price targets available for MRCIF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $254.28B | $279.30B | $295.32B | $330.73B |
| Low | $233.70B | $256.70B | $271.42B | $303.97B |
| High | $276.03B | $303.20B | $320.59B | $359.03B |
| EBITDA Avg | $78.29B | $86.00B | $90.93B | $101.83B |
| Low | $71.96B | $79.04B | $83.57B | $93.59B |
| High | $84.99B | $93.36B | $98.71B | $110.54B |
| EBIT Avg | $75.17B | $82.57B | $87.31B | $97.77B |
| Low | $69.09B | $75.89B | $80.24B | $89.86B |
| High | $81.60B | $89.64B | $94.78B | $106.14B |
| Net Income Avg | $36.98B | $42.53B | $43.27B | $48.29B |
| Low | $33.09B | $38.06B | $38.72B | $43.21B |
| High | $41.09B | $47.26B | $48.08B | $53.66B |
| EPS Avg | $219.27 | $252.19 | $256.57 | $286.35 |
| Low | $196.20 | $225.66 | $229.58 | $256.22 |
| High | $243.66 | $280.24 | $285.11 | $318.20 |
| Analysts (Rev / EPS) | 13 / 1 | 5 / 1 | 9 / 1 | 12 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $58.76B | $65.40B | $66.70B | $64.41B |
| Low | $58.76B | $65.40B | $66.70B | $64.41B |
| High | $58.76B | $65.40B | $66.70B | $64.41B |
| EBITDA Avg | $18.09B | $20.14B | $20.54B | $19.83B |
| Low | $18.09B | $20.14B | $20.54B | $19.83B |
| High | $18.09B | $20.14B | $20.54B | $19.83B |
| EBIT Avg | $17.37B | $19.33B | $19.72B | $19.04B |
| Low | $17.37B | $19.33B | $19.72B | $19.04B |
| High | $17.37B | $19.33B | $19.72B | $19.04B |
| Net Income Avg | — | — | — | — |
| Low | — | — | — | — |
| High | — | — | — | — |
| EPS Avg | — | — | — | — |
| Low | — | — | — | — |
| High | — | — | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — | 1 / — | 1 / — |